New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
The causes of Parkinson disease (PD) remain mysterious, although some evidence supports mitochondrial dysfunctions and α-synuclein accumulation in Lewy bodies as major events. The abnormal accumulation of α-synuclein has been associated with a deficiency in the ubiquitin-proteasome system and the au...
Main Authors: | Sonia Lehri-Boufala, Mohand-Ouidir Ouidja, Véronique Barbier-Chassefière, Emilie Hénault, Rita Raisman-Vozari, Laure Garrigue-Antar, Dulce Papy-Garcia, Christophe Morin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4305359?pdf=render |
Similar Items
-
Glycosaminoglycans from Alzheimer's disease hippocampus have altered capacities to bind and regulate growth factors activities and to bind tau.
by: Minh Bao Huynh, et al.
Published: (2019-01-01) -
Les Glycosaminoglycannes : nouveaux régulateurs de l’agrégation de l’α-synucléine et de l’apoptose dans un modèle cellulaire de la maladie de Parkinson
by: Lehri-Boufala, Sonia
Published: (2011) -
Rifampicin quinone pretreatment improves neuronal survival by modulating microglia inflammation induced by α-synuclein
by: Leonardo Acuna, et al.
Published: (2020-01-01) -
Rifampicin and Its Derivative Rifampicin Quinone Reduce Microglial Inflammatory Responses and Neurodegeneration Induced In Vitro by α-Synuclein Fibrillary Aggregates
by: Leonardo Acuña, et al.
Published: (2019-07-01) -
The Effect of Glycosaminoglycans (GAGs) on Amyloid Aggregation and Toxicity
by: Clara Iannuzzi, et al.
Published: (2015-02-01)